BioCryst Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
Good afternoon, everyone. Welcome to Barclays Global Healthcare Conference. My name is Gena Wang. I'm a SMid-cap biotech analyst. It's my great pleasure to introduce our next presenting company, BioCryst Pharmaceuticals.
With us today, we have Jon Stonehouse, President and Chief Executive Officer; Charlie Gayer, Chief Commercial Officer; and then John Bluth, Chief Communication Officer.
So Jon, maybe before we dive into specific questions, do you want to give a high-level overview of the company?
Yes, I'd be happy to. And first, let me say thank you for inviting us to this conference. It's wonderful to see people in person instead of doing this through Zoom. So it's great to be here in Miami with you, and really enjoyed the day so far.
So I'll be making some forward-looking statements, these guys will be too. And those will have associated risks and the risk factors could
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
